TGTGInsighttelegram intelligenceLIVE / telegram public index
← IT news | Tg Bots

TGINSIGHT SIMILAR POSTS

유사한 콘텐츠 찾기

소스 채널 @phpdevelopersuz · Post #2990 · 12월 31일

Bot API was updated to version 6.4 Forums • Bots can now open, close, edit and toggle the visibility of the General Topic. • Added support for new service messages, like ForumTopicEdited, GeneralForumTopicHidden and more. • The method sendChatAction can now send actions to any thread or topic via the message_thread_id parameter. Spoilers • Added spoiler detection via the new has_media_spoiler field in the Message class. • Bots can send media covered by a spoiler animation via the has_spoiler field in sendPhoto, sendVideo and sendAnimation. Web Apps • Added a native QR scanner popup, controllable via showScanQrPopup and closeScanQrPopup. • Web Apps launched from the attachment menu can request clipboard text via readTextFromClipboard. • Added a platform field, showing which platform the web app is being used on. General • Added the is_persistent field, to keep ReplyKeyboards open by default. See the full changelog for details on the official website. #update#BotAPI https://t.me/+VMLgtEPNL49jZmNh

결과

2개의 유사한 게시물이 발견되었습니다

검색: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 2026. 04. 09. AM 01:45

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 2024. 12. 21. AM 10:23

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment